VCAM1 and rheumatoid arthritis: More precisely, lower VCAM-1 levels (1172.4 ± 736.9 ng/mL) were found after DMARD therapy initiation than were observed in non-treated patients with RA (2239.8 ± 1437.4 ng/mL; P < 0.050).